Mutational analysis of the human immunodeficiency virus type 1 Vpu transmembrane domain that promotes the enhanced release of virus-like particles from the plasma membrane of mammalian cells

Journal of Virology

Volumn 72, Issue 2, 1998, Pages 1270-1279

  Paul, Mousumi ^a   Mazumder, Suparna ^a   Raja, Nicholas ^a   Jabbar, M Abdul ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; PHOSPHOPROTEIN; VPU PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DELETION MUTANT; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS GENE; VIRUS PARTICLE;

EID: 0031908685     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.2.1270-1279.1998     Document Type: Article

References (73)

1. Aiken, C., J. Konner, N. R. Landau, M. E. Lenburg, and D. Truno. 1994. Nef induces CD4 endocytosis: requirement for a critical di leucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76:853-864.
2. Balleit, J. W., D. L. Kolson, G. Eiger, F. M. Kim, K. A. McGann, A. Srinivasan, and R. Collman. 1994. Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary isolate. Virology 200:623-623.
3. Baur, A. S., E. T. Sawai, P. Dazin, W. J. Fantl, C. Chen-Mayer, and B. M. Peterlin. 1994. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1:373-384.
4. Bour, S., and K. Strebel. 1996. The human immunodeficiency virus (HIV) type 2 envelope glycoprotein is a functional complement of to HIV-1 Vpu that enhances particle release of heterologous retroviruses. J. Virol. 70:8285-8300.
5. Bour, S., R. Geleziunas, and M. A. Wainberg. 1995. The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection. Microbiol. Rev. 59:63-93.
6. Bour, S., U. Schubert, and K. Strebel. 1995. The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation. J. Virol. 69:1510-1520.
7. Bour, S., U. Schubert, K. Peden, and K. Strebel. 1996. The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor? J. Virol. 70:820-829.
8. Buonocore, L., T. G. Turi, B. Crise, and J. K. Rose. 1994. Stimulation of heterologous protein degradation by the Vpu protein of HIV-1 requires the transmembrane and cytoplasmic domains of CD4. Virology 204:482-486.
9. Chen, B. K., R. T. Gandhi, and D. Baltimore. 1996. CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef. J. Virol. 70:6044-6053.
10. Chen, M.-T., F. Malderelli, M. K. Karczewski, R. L. Willey, and K. Strebel. 1993. Human immunodeficiency virus type 1 Vpu protein induces degradation of CD4 in vitro: the cytoplasmic domain of CD4 contributes to Vpu sensitivity. J. Virol. 67:3877-3884.
11. Cohen, E. A., E. F. Terwilliger, J. G. Sodroski, and W. A. Haseltine. 1988. Identification of a protein encoded by the vpu gene of HIV-1. Nature (London) 334:532-534.
12. Collman, R., J. W. Balleit, S. A. Gregory, H. Friedman, D. L. Kolson, N. Nathanson, and A. Srinivasan. 1992. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J. Virol. 66:7517-7521.
13. Crise, B., L. Buonocore, and J. K. Rose. 1990. CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus envelope glycoprotein precursor. J. Virol. 64:5585-5593.
14. Cullen, B. R. 1994. The role of Nef in the replication cycle of the human and simian immunodeficiency viruses. Virology 205:1-6.
15. Doms, R. W., R. A. Lamb, J. K. Rose, and A. Helenius. 1993. Folding and assembly of viral membrane proteins. Virology 193:545-562.
16. Earl, P. L., B. Moss, and R. W. Doms. 1991. Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein. J. Virol. 65:2047-2055.
17. Ewart, G. D., T. Sutherland, P. W. Gage, and G. B. Cox. 1996. The Vpu protein of human immunodeficiency virus type forms cation-selective ion channels. J. Virol. 70:7108-7115.
18. Facke, M., A. Janetzko, R. L. Shoeman, and H. G. Kräusslich. 1993. A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum. J. Virol. 67:4972-4980.
19. Friborg, J., Z. Ladha, H. Göttlinger, W. A. Haseltine, and E. A. Cohen. 1995. Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 8:10-22.
20. Fuerst, T. R., P. L. Earl, and B. Moss. 1987. Use of a hybrid virus-T7 RNA polymerase system for expression of target genes. Mol. Cell. Biol. 7:2538-2544.
21. Garcia, R. J., and A. D. Miller. 1991. Serine phosphorylation-independent down-regulation of cell surface CD4 by nef. Nature (London) 350:508-511.
22. Gelderblom, H. R. 1991. Assembly and morphology of HIV: potential effect of structure on viral function. AIDS 5:617-637.
23. Geraghty, R. J., and A. T. Panganiban. 1993. Human immunodeficiency virus type 1 Vpu has a CD4-and an envelope glycoprotein-independent function. J. Virol. 67:4190-4194.
24. Göttlinger, H. G., T. Dorfman, E. A. Cohen, and W. A. Haseltine. 1993. Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc. Natl. Acad. Sci. USA 90:7381-7385.
25. Göttlinger, H. G., T. Dorfman, J. G. Sodroski, and W. A. Haseltine. 1989. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:5781-5785.
26. Haffar, O., J. Garrigues, B. Travis, P. Moran, J. Zarling, and S. L. Hu. 1990. Human immunodeficiency virus-like, nonreplicating, gag-env particles assemble in a recombinant vaccinia virus expression system. J. Virol. 64:2653-2659.
27. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59.
28. 2 ion channel protein: a structure-function analysis. J. Virol. 68:1551-1563.
29. Hunter, E. 1994. Macromolecular interactions in the assembly of HIV and other retroviruses. Semin. Virol. 5:71-83.
30. Jabbar, M. A. 1995. The human immunodeficiency virus type 1 Vpu protein: roles in virus release and CD4 down-modulation. Curr. Top. Microbiol. Immunol. 193:107-120.
31. Jabbar, M. A., and D. P. Nayak. 1990. Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane. J. Virol. 64:6297-6304.
32. Kaplan, A. H., and R. Swanstrom. 1991. Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments. Proc. Natl. Acad. Sci. USA 88:4528-4532.
33. Klimkait, T., K. Strebel, M. D. Hoggan, M. A. Martin, and J. M. Orenstein. 1990. The human immunodeficiency virus type 1-specific protein Vpu is required for efficient virus maturation and release. J. Virol. 64:621-629.
34. Lamb, R. A., and L. H. Pinto. 1997. Do Vpu and Vpr of human immunodeficiency virus type 1 and of influenza B virus have ion channel activities in the virus life cycles? Virology 229:1-11.
35. Lenburg, M. E., and N. R. Landau. 1993. Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4. J. Virol. 67:7238-7245.
36. Mahalingam, S., S. A. Khan, M. A. Jabbar, C. Monken, R. Collman, and Srinivasan, A. 1995. Identification of residues in the N-terminal acidic domain of HIV-1 Vpr essential for virion incorporation. Virology 207:297-302.
37. Maldarelli, F., M.-Y. Chen, R. L. Willey, and K. Strebel. 1993. Human immunodeficiency virus type 1 Vpu protein is an oligomeric type 1 integral membrane protein. J. Virol. 67:5056-5061.
38. Marban, E., and G. E. Tomaselli. 1997. Ion channels as enzymes: analogy or homology. Trends Neurosci. 20:144-147.
39. Paul, M., and M. A. Jabbar. 1997. Phosphorylation of both phosphoacceptor sites in the HIV-1 Vpu cytoplasmic domain is essential for Vpu-mediated ER degradation of CD4. Virology 232:207-216.
40. Paul, M., and M. A. Jabbar. Unpublished observations.
41. Pinto, L. H., L. J. Holsinger, and R. A. Lamb. 1992. Influenza virus M2 protein has ion channel activity. Cell 69:517-528.
42. Platt, E. J., and O. K. Haffar. 1994. Characterization of human immunodeficiency virus type 1 Pr55gag membrane association in a cell-free system: requirement for a C-terminal domain. Proc. Natl. Acad. Sci. USA 91:4594-4598.
43. Raja, N. U., and M. A. Jabbar. 1996. The human immunodeficiency virus type 1 Vpu protein tethered to the CD4 extracellular domain is localized to the plasma membrane and is biologically active in the secretory pathway of mammalian cells: implications for the mechanisms of Vpu function. Virology 220:141-151.
44. Raja, N. U., M. J. Vincent, and M. A. Jabbar. 1993. Analysis of endoprotcolytic cleavage, and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal. J. Gen. Virol. 74: 2085-2097.
45. Raja, N. U., M. J. Vincent, and M. A. Jabbar. 1994. Vpu-mediated proteolysis of gp160/CD chimeric envelope glycoproteins in the endoplasmic reticulum: requirement for both the anchor and cytoplasmic domains of CD4. Virology 204:357-366.
46. Ritter, G. D., Jr., G. Yamshchikov, S. J. Cohen, and M. J. Mulligan. 1996. Human immunodeficiency virus type 2 enhancement of particle budding: role of the cytoplasmic domain. J. Virol. 70:2669-2673.
47. Sakaguchi, T., G. P. Leser, and R. A. Lamb. 1996. The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus. J. Cell Biol. 133:733-747.
48. Sakaguchi, T., Q. Tu, L. H. Pinto, and R. A. Lamb. 1997. The active oligomeric state of the minimalistic influenza virus M2 ion channel is a tetramer. Proc. Natl. Acad. Sci. USA 94:5000-5005.
49. Schubert, U., A. V. Ferrer-Montal, M. Oblatt-Montal, P. Henklein, K. Strebel, and M. Montal. 1996. Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-infected cells. FEBS Lett. 378:12-18.
50. Schubert, U., and K. Strebel. 1994. Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J. Virol. 68:2260-2271.
51. Schubert, U., K. Clouse, and K. Strebel. 1995. Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes. J. Virol. 69:7699-7711.
52. Schubert, U., S. Bour, A. V. Ferrer-Montiel, M. Mantiel, F. Maldarelli, and K. Strebel. 1996. The two biological activities of human immunodeficiency virus type 1 Vpu protein involves two separable structural domains. J. Virol. 70:809-819.
53. Schwartz, M. D., R. J., Geraghty, and A. T. Panganiban. HIV particle release mediated by Vpu is distinct from that mediated by p6. Virology 224:302-309.
54. Schwartz, S., B. K. Felber, E. M. Fenyo, and G. N. Pavlakis. 1990. Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs. J. Virol. 64:5448-5456.
55. Spearman, P., J.-J. Wang, N. V. Heyden, and L. Ratner. 1994. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J. Virol. 68:3232-3242.
56. Strebel, K., T. Klimkait, and M. A. Martin. 1988. A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science 241:1221-1223.
57. Strebel, K., T. Klimkait, F. Maldarelli, and M. A. Martin. 1989. Molecular and biochemical analyses of human immunodeficiency virus type 1 Vpu protein. J. Virol. 63:3784-3791.
58. Terwilliger, E. F., E. A. Cohen, Y. Lu, J. G. Sodroski, and W. A. Haseltine. 1989. Functional role of human immunodeficiency virus type 1 vpu. Proc. Natl. Acad. Sci. USA 86:5163-5167.
59. Tiganos, E., X.-Y. Yao, J. Friforg, N. Daniel, and E. A. Cohen. 1997. Putative α-helical structures in the human immunodeficiency virus type 1 Vpu protein and CD4 are involved in binding and degradation of the CD4 molecule. J. Virol. 71:4452-4460.
60. Trono, D. 1995. HIV accessory proteins: leading role for the supporting cast. Cell 82:189-192.
61. Vincent, M. J., and M. A. Jabbar. 1995. The human immunodeficiency virus type 1 Vpu protein: a potential regulator of proteolysis and protein trafficking in the secretory pathway of mammalian cells. Virology 213:639-649.
62. Vincent, M. J., N.U. Raja, and M. A. Jabbar. 1993. The human immunodeficiency virus Vpu protein induces degradation of chimeric envelope glycoproteins hearing the cytoplasmic and anchor domains of CD4: role of cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum. J. Virol. 67:5538-5549.
63. Wang, C.-T., and E. Barklis. 1993. Assembly, processing, and infectivity of human immunodeficiency virus type 1 Gag mutants. J. Virol. 67:4264-4273.
64. Willey, R. L., A. Buckler-White, and K. Strebel. 1994. Sequences present in the cytoplasmic domain of CD4 are necessary and sufficient to confer sensitivity to the human immunodeficiency virus type I Vpu protein. J. Virol. 68:1207-1212.
65. Willey, R. L., F. Maldarelli, M. A. Martin, and K. Strebel. 1992. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol 66:7193-7200.
66. Willey, R. L., F. Maldarelli, M. A. Martin, and K. Strebel. 1992. Human immunodeficiency virus type I Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J. Virol. 66:226-234.
67. Wills, J. W., and R. C. Craven. 1991. Form, function, and use of retroviral Gag proteins. AIDS 5:639-654.
68. Yao, X.-J., J. Friborg, F. Checroune, S. Gratton, F. Boisvert, R. P. Sekaly, and E. A. Cohen. 1995. Degradation of CD4 by human immunodeficiency virus type 1 Vpu protein: a predicted alpha-helix structure in the proximal cytoplasmic region of CD4 contributes to Vpu sensitivity. Virology 209:615-623.
69. Yao, X. J., S. Garzon, F. Boisvert, W. A. Haseltine, and E. A. Cohen. 1993. The effect of vpu on HIV-1-induced syncytia formation. J. Acquired Immune Defic. Syndr. 6:135-141.
70. Yao, X.-J., H. Gottlinger, W. A. Haseltine, and E. A. Cohen. 1992. Envelope glycoprotein and CD4 independence of vpu-facilitated human immunodeficiency virus type 1 capsid export. J. Virol. 66:5119-5126.
71. Yu, G., F. S. Shen, S. Sturch, A. Aquino, R. I. Glazer, and R. I. Felsted. 1995. Regulation of HIV-1 gag protein subcellular targeting by protein kinase C. J. Biol. Chem. 270:4792-4796.
72. Yuan, X., X. Yu, T.-H. Lee, and M. Essex. 1993. Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J. Virol. 67:6387-6394.
73. Zhou, W., L. J. Parent, J. W. Wills, and M. D. Resh. 1994. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 protein which interacts with acidic phospholipids. J. Virol. 68:2556-2569.